[Use of naphthidon as a radiosensitizer in radiotherapy of patients with malignant neoplasms].
D000328:Adult; D004938:Esophageal Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009285:Naphthoquinones / Q000627:therapeutic use*; D010534:Peritoneal Neoplasms / Q000532:radiotherapy*; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D011879:Radiotherapy Dosage; D012004:Rectal Neoplasms / Q000532:radiotherapy*; D001749:Urinary Bladder Neoplasms / Q000532:radiotherapy*
D009285:Naphthoquinones; D011838:Radiation-Sensitizing Agents
Primenenie naftidona v kachestve radiosensibilizatora pri luchevoi terapii bol'nykh zlokachestvennymi novoobrazovaniiami.